Primary Sclerosing Cholangitis: Current and Future Management Strategies.

about

Biliary strictures and masses: an expanded differential diagnosis.Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience.

P2860

Q41580533-C8C92482-994D-43F0-BA63-C532681EA65E Q55210660-334F7B40-F723-4765-9780-2B7E435C3989

P2860

Primary Sclerosing Cholangitis: Current and Future Management Strategies.

Item

http://www.wikidata.org/entity/Q38107484

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Primary Sclerosing Cholangitis: Current and Future Management Strategies.

@en

type

Item

label

Primary Sclerosing Cholangitis: Current and Future Management Strategies.

@en

prefLabel

Primary Sclerosing Cholangitis: Current and Future Management Strategies.

@en

P1476

Primary Sclerosing Cholangitis: Current and Future Management Strategies.

@en

P2093

Jayant A Talwalkar

http://www.w3.org/2001/XMLSchema#string

John E Eaton

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis

A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice

Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice.

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.

Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis.

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.

P304

28-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11901-012-0155-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23682242

http://www.w3.org/2001/XMLSchema#string

P921

cholangitis

P932

3652489

http://www.w3.org/2001/XMLSchema#string

Primary Sclerosing Cholangitis: Current and Future Management Strategies.

about

P2860

P2860

Primary Sclerosing Cholangitis: Current and Future Management Strategies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932